Glaxo SmithKline Share Price Target for 2023 to 2050 is based on the company’s growth prospects:— GlaxoSmithKline (GSK) is a leading pharmaceutical company with a global presence and a diverse portfolio of products. The company is known for its innovative research and development, as well as its focus on improving the health and well-being of people around the world.
In this blog post, we will take a closer look at Glaxo SmithKline share price target with a comprehensive overview of the company’s stock price. So, whether you are a long-time shareholder or are considering investing in Glaxo SmithKline for the first time, we will also provide an analysis of Glaxo SmithKline performance and the outlook for its future growth.
it’s Your Favorite…
Glaxo SmithKline Overview
Glaxo SmithKline, commonly known as GSK, is a British multinational pharmaceutical company that operates in the healthcare and pharmaceutical industry. It was founded in 2000 following a merger between Glaxo Wellcome and SmithKline Beecham. GSK has its headquarters in Brentford, London, UK, and serves customers across the globe.
Industry: GSK operates in the healthcare and pharmaceutical industry. The company is involved in the development, manufacture, and distribution of prescription medicines, vaccines, and consumer healthcare products.
Founded: GSK was founded on December 27, 2000, following a merger between Glaxo Wellcome and SmithKline Beecham.
Founder: GSK was not founded by a single individual. It was formed through a merger of two leading pharmaceutical companies at the time. Glaxo Wellcome was founded in 1995 as a result of a merger between Glaxo and Burroughs Wellcome, while SmithKline Beecham was a product of a merger between SmithKline Beckman and Beecham Group in 1989.
Headquarters: GSK’s headquarters are located in Brentford, London, UK. The company has operations in over 100 countries worldwide and has research centers and manufacturing facilities in multiple locations.
Area served: GSK serves customers globally, with operations in over 100 countries. The company has a strong presence in the UK, US, Europe, Asia, and Africa.
Products: GSK’s product portfolio includes prescription medicines, vaccines, and consumer healthcare products. Some of the popular prescription drugs manufactured by GSK include Advair, Trelegy, and Augmentin. The company is also a leading producer of vaccines, including those for meningitis, hepatitis, and influenza. Additionally, GSK produces consumer healthcare products such as Sensodyne toothpaste and Panadol pain relief medication.
Services: GSK offers a wide range of healthcare services, including disease prevention, diagnosis, and treatment. The company is committed to developing innovative medicines and vaccines to address the unmet medical needs of patients worldwide.
Website URL: The company’s website is www.gsk.com. The website provides information on the company’s products and services, as well as its corporate governance, sustainability, and financial performance. Customers can also find information on the company’s clinical trials, research partnerships, and career opportunities.
One way to check the Glaxo SmithKline share price target/forecast is to look at the research reports and analysis provided by financial institutions and brokerage firms. These firms often provide detailed reports on the company’s financials and future outlook, along with recommendations and target prices.
| DATE | AUTHOR | TARGET |
|---|---|---|
| 16 MAR 2023 | Motilal Oswal | 1300.00 |
| 08 FEB 2023 | ICICI Securities Limited | 1448.00 |
| 14 NOV 2022 | ICICI Securities Limited | 1413.00 |
| 12 NOV 2022 | Motilal Oswal | 1420.00 |
| 24 AUG 2022 | ICICI Securities Limited | 1456.00 |
| 26 JUL 2022 | Motilal Oswal | 1580.00 |
| 16 MAY 2022 | Motilal Oswal | 1570.00 |
| Telegram Channel | 👉 Click Here ☑ |
| Facebook Page | 👉 Click Here ☑ |
As an investor, you may be wondering what the future holds for Glaxo SmithKline and its share price. we’ll take a look at the current state of Glaxo SmithKline and try to predict what is Glaxo SmithKline share price target for 2023, 2025, 2027, 2030, 2035, 2040, and 2050 is based on the company’s growth prospects:—
| Years | 1st Target | 2nd Target |
|---|---|---|
| 2023 | ₹1200 | ₹1400 |
| 2024 | ₹1300 | ₹1500 |
| 2025 | ₹1400 | ₹1600 |
| 2026 | ₹1500 | ₹1700 |
| 2027 | ₹1600 | ₹1800 |
| 2030 | ₹1800 | ₹2000 |
| 2040 | ₹2200 | ₹2500 |
| 2050 | ₹2800 | ₹3200 |
Our analysis suggests that GSK share prices will likely range between INR 1200 to INR 1400 in 2023. This is based on the company’s strong financials and its focus on innovation and growth.
We predict that GSK share prices will likely range between INR 1300 to INR 1500 in 2024. This is based on the company’s solid pipeline of products and its strategic focus on research and development.
Our analysis suggests that GSK share prices will likely range between INR 1400 to INR 1600 in 2025. This is based on the company’s strong presence in emerging markets and its commitment to expanding its product portfolio.
We predict that GSK share prices will likely range between INR 1500 to INR 1700 in 2026. This is based on the company’s continued focus on research and development and its strong financial performance.
Our analysis suggests that GSK share prices will likely range between INR 1600 to INR 1800 in 2027. This is based on the company’s strong pipeline of products and its strategic focus on growth in emerging markets.
We predict that GSK share prices will likely range between INR 1800 to INR 2000 in 2030. This is based on the company’s strong financials, its focus on innovation and growth, and the potential for new blockbuster drugs in its pipeline.
Our analysis suggests that GSK share prices will likely range between INR 2200 to INR 2500 in 2040. This is based on the company’s continued focus on research and development, its strong financial performance, and the potential for growth in emerging markets.
We predict that GSK share prices will likely range between INR 2800 to INR 3200 in 2050. This is based on the company’s long-term strategic plan, its continued focus on innovation and growth, and the potential for new blockbuster drugs in its pipeline.
— We’ll take a look at the current state of Glaxo SmithKline and try to predict share price targets for each year from 2023 to 2050.
— As of 19 March 2023, the current share price of Glaxo SmithKline Limited is INR 1,282 Rs. Check out the latest price of Glaxo SmithKline.
— To determine the Glaxo SmithKline share price target today or tomorrow We will also provide an analysis of Glaxo SmithKline performance and the outlook for its future growth.
— The last research report published by Motilal Oswal was on 16 MAR 2023, In this case, Motilal Oswal has set a target price of 1300 Rs. for Glaxo SmithKline stock.
That these share price targets for “Glaxo SmithKline” are only provided for informational purposes only. It does not constitute a recommendation to buy, sell or hold Glaxo SmithKline stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions.
